![]() |
|
|
L Gong, RM Kostrzewa, RW Fuller and KW Perry
Department of Pharmacology, James H. Quillen College of Medicine, East Tennessee State University, Johnson City.
To study possible interactions between dopamine (DA) and serotonin (5- HT) neurochemical systems in the D-1 supersensitized induction of oral activity in neonatal 6-hydroxydopamine (6-OHDA) lesioned rats, the effects of a series of 5-HT agonists and antagonists were determined. At 3 days after birth rats were treated with desipramine HCl (20 mg/kg i.p., base form, 1 hr) and 6-OHDA HBr (100 micrograms, salt form, in each lateral ventricle). Rats were observed individually as adults, once a minute every 10 min over a 1-hr period after challenge with a DA or 5-HT receptor agonist. The respective 5-HT1A and 5-HT1B agonists, (+/-)-8-hydroxydipropylaminotetralin (0.50 mg/kg s.c.) and CGS 12066B maleate (7-trifluoromethyl-4(4-methyl-1-piperazinyl)-pyrrolo[1, 2- alquinoxaline], 1:2 maleate salt; 3.0 mg/kg i.p.), did not increase oral activity. The mixed 5-HT1C and 5-HT2 receptor agonist, m- chlorophenylpiperazine (m-CPP), produced a slight increase in oral activity in control rats and a marked increase in oral activity in 6- OHDA-lesioned rats. In the 6-OHDA group the peak effect of 76.5 +/- 4.1 oral movements occurred with an m-CPP 2-HCl dose of 4.0 mg/kg. Pindolol (1.0 mg/kg i.p.), ketanserin tartrate (5 mg/kg i.p.) and MDL-72222 (3- tropanyl-3,5-dichlorobenzoate; 10 mg/kg s.c.), antagonists with high affinity for 5-HT1A,1B, 5-HT2 and 5-HT3 receptors, respectively, did not attenuate m-CPP actions. However, mianserin HCl (1.0 mg/kg s.c.), an antagonist with high affinity for 5-HT1C and 5-HT2 receptors, attenuated the oral response to m-CPP.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
P. De Deurwaerdere and M.-F. Chesselet Nigrostriatal Lesions Alter Oral Dyskinesia and c-Fos Expression Induced by the Serotonin Agonist 1-(m-Chlorophenyl)piperazine in Adult Rats J. Neurosci., July 1, 2000; 20(13): 5170 - 5178. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Granon, F. Passetti, K. L. Thomas, J. W. Dalley, B. J. Everitt, and T. W. Robbins Enhanced and Impaired Attentional Performance After Infusion of D1 Dopaminergic Receptor Agents into Rat Prefrontal Cortex J. Neurosci., February 1, 2000; 20(3): 1208 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-Y. Huang, R. M. Kostrzewa, C. Li, K. W. Perry, and R. W. Fuller Persistent Spontaneous Oral Dyskinesias in Haloperidol-Withdrawn Rats Neonatally Lesioned with 6-Hydroxydopamine: Absence of an Association with the Bmax for [3H]Raclopride Binding to Neostriatal Homogenates J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 268 - 276. [Abstract] [Full Text] |
||||
![]() |
N. Laprade, F. Radja, T. A. Reader, and J.-J. Soghomonian Dopamine Receptor Agonists Regulate Levels of the Serotonin 5-HT2A Receptor and its mRNA in a Subpopulation of Rat Striatal Neurons J. Neurosci., June 1, 1996; 16(11): 3727 - 3736. [Abstract] [Full Text] [PDF] |
||||